You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南微醫學(688029.SH):2019年度歸母淨利潤預增約55.8%
格隆匯 01-19 17:30

格隆匯1月19日丨南微醫學(688029.SH)發佈2019年年度業績預告,經財務部門初步測算,預計2019年年度實現歸屬於母公司所有者的淨利潤為3.0023億元左右(人民幣,下同),與上年同期(法定披露數據)相比,將增加1.0753億元左右,同比增加55.80%左右;歸屬於母公司所有者的扣除非經常性損益的淨利潤為2.7003億元左右,與上年同期(法定披露數據)相比,將增加9483.64萬元左右,同比增加54.13%左右。

公告表示,報告期內,公司積極開拓全球市場、加大研發投入,業務規模不斷擴大。中國和美國市場繼續保持了較高的增速;止血及閉合類、ERCP類、ESD/EMR類等產品的銷量快速增長。通過工藝技術優化、改善管理,公司的產能、運營效率和成本控制能力得到提升,綜合毛利率較上年有所增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account